Le terapie farmacologiche per la cura dell’artrite psoriasica hanno l’obiettivo principale di attenuare il dolore e ridurre il gonfiore preservando un corretto funzionamento delle articolazioni e prevenendo ulteriori danni. Esistono diverse opzioni farmacologiche per il trattamento dell’artrite psoriasica, il medico sceglierà quella più idonea al caso a seconda della tipologia di artrite psoriasica, della gravità dei sintomi e della tolleranza/risposta del singolo paziente alla terapia.
Le terapie per l’artrite psoriasica
Bibliografia
- Arthritis Foundation, “Psoriatic Arthritis Treatment”, http://www.arthritis.org/about-arthritis/types/psoriatic-arthritis/treatment.php [visitato in data 20/11/2017].
- Coates L. C. et al., “Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis”, ARTHRITIS & RHEUMATOLOGY Vol. 68, No. 5, 2016, 1060–1071.
- Gossec L. et al., “European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies”, Ann. Rheum. Dis., 2012; 71:4–12.
- Husni M. E. et al., “The psychosocial burden of psoriatic arthritis”, Seminars in Arthritis and Rheumatism 47, 2017, 351–360
- Jani M. et al., “Pharmacogenetics of Treatment Response in Psoriatic Arthritis”, Curr. Rheumatol. Rep.,2015, 17: 44
- Mease P. J. and Armstrong A. W., “Managing Patients with Psoriatic Disease: The Diagnosis and Pharmacologic Treatment of Psoriatic Arthritis in Patients with Psoriasis”, Drugs, 2014, 74:423–441.
- Merola J. F. et al., “Switching biologics in the treatment of psoriatic arthritis” Seminars in Arthritis and Rheumatism, 47, 2017, 29–37.
- Palfreeman A. C. et al., “New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast”, Drug Design, Development and Therapy, 2013, 7, 201–210.
- Patel N. U. et al., “A Review of the Use of Secukinumab for Psoriatic Arthritis”, Rheumatol Ther., 2017, DOI 10.1007/s40744-017-0076-0.
- Perrotta F.M., Lubrano E., “New approved drugs for psoriatic arthritis”, Reumatismo, 2016; 68 (2): 57-64.
- Raychaudhuri S.P. et al., “Management of psoriatic arthritis: Early diagnosis, monitoring of disease severity and cutting edge therapies”, Journal of Autoimmunity 76, 2017, 21-37.Sarzi-Puttini P. and Atzeni F., “New Biological Treatments for Psoriatic Arthritis”, IMAJ, 2014, Vol 16.
